THALES AVIONICS LIMITED

Financial Health Score: B (Stable but Inactive)

Explanation: Thales Avionics Limited is not suffering from financial distress; rather, it is in a state of deliberate corporate hibernation. As a dormant subsidiary of a larger corporate entity (Thales UK Limited), it carries zero financial risk but also generates zero commercial vitality. It is perfectly healthy for a non-trading entity, maintaining full regulatory compliance, but receives a 'B' rather than an 'A' due to the complete absence of active trading metabolism.

Key Vital Signs

• Pulse (Trading Activity): Flatline. The SIC code (99999) explicitly confirms the company is dormant. There is no heartbeat in terms of revenue generation, operating cash flow, or trading activity.
• Blood Pressure (Regulatory Compliance): Normal. The company’s filing vital signs are strong. Accounts are up to date (made up to 31 Dec 2025) and the confirmation statement is current, with no overdue filings. This shows the "caregivers" (the directors and secretary) are maintaining the entity's legal life support effectively.
• Body Mass (Capitalisation): Minimal. With a share capital of exactly £1, the company is maintaining the absolute minimum legal mass required to exist as a corporate entity. It has no retained earnings or P&L reserves visible, which is typical for a dormant shell.
• Nervous System (Corporate Control): Fully Intact. The parent company, Thales UK Limited, holds more than 75% of the shares, possesses more than 75% of the voting rights, and retains the right to appoint and remove directors. The subsidiary's actions are entirely directed by its parent organism.

Diagnosis

Corporate Hibernation with Historical Significance

The financial data reveals that Thales Avionics Limited is a dormant shell company. It is not sick; it is simply resting. The "patient" has a long medical history, having been incorporated over 70 years ago in 1953, and previously operated actively under the names Racal Avionics and Thomson Racal Avionics. However, at some point in its lifecycle, the business was restructured, and its active operations were likely absorbed into the wider Thales group.

Currently, the company shows no symptoms of distress—no debt, no overdue obligations, and no risk of insolvency. However, it also shows no signs of active business health. It exists purely as a legal entity, likely retained by the Thales group to preserve the proprietary name, hold specific intellectual property, or maintain a corporate structure for potential future use.

Recommendations

1. Maintain the Life Support: The primary recommendation is to continue current practices. The directors must ensure that the company remains strictly dormant. Any accidental trading or financial transaction could "wake the patient up," requiring full financial resuscitation in the form of statutory accounts and potential tax liabilities.
2. Periodic Viability Review: While the company costs very little to keep on life support (mainly just the administrative time for the director and secretary), the Thales group should conduct an annual review to determine if the entity is still required. If the "Thales Avionics" name or the specific corporate shell is no longer strategically necessary, a voluntary strike-off (dissolution) could remove the need for ongoing administrative maintenance.
3. Asset Audit: Even though the company is dormant, ensure that no latent assets (such as historical intellectual property, patents, or trademarks) are at risk. If the company holds any such intangible assets, the £1 share capital and dormant status must be strictly maintained to protect them.